Blog - Page 2245 of 5718

WednesdayAug 15, 2018 12:41 pm

CytoDyn Inc. (CYDY) Sees Promising HIV Treatment Trial Results, Gets Go-Ahead to Raise Dosage

Response rate to PRO 140 rose from 40 percent at 350mg dose to 70 percent at 525mg Institutional Review Board (IRB) allows trials of viral-entry inhibitor to continue at 700mg dose PRO 140 is an FDA fast-track candidate Following clinical trial results showing that its new anti-HIV treatment is more effective at higher dosages, biotechnology company CytoDyn Inc. (OTCQB: CYDY) is set to give trial participants an increased weekly dose of PRO 140 (http://ibn.fm/oyLRe). The latest round of trial results showed that the response rate among trial participants treated with the viral-entry inhibitor rose from 40 percent at a 350mg weekly…

WednesdayAug 15, 2018 12:17 pm

MIDS Cardiac by Zenosense, Inc. (ZENO): A Heart Attack Diagnostic Revolution?

The handheld testing device technology under development by Zenosense aims to deliver rapid results and state-of-the-art, laboratory-accurate results for the quick diagnosis of heart attacks Medical professionals believe that diagnosis within 30 minutes of a heart attack is the golden standard for ensuring adequate treatment Cardiac diagnostic testing market estimated between $2 billion and $6 billion in the U.S. alone MIDS Cardiac™, a handheld diagnostic device for cardiac emergency triage being developed by Zenosense, Inc. (OTCQB: ZENO), could prove to be revolutionary in the diagnostic process. Incorporating the patented MIDS technology, which is predicated on the nano-magnetic detection of assay…

WednesdayAug 15, 2018 12:13 pm

QualityStocksNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and WeedMD Inc. (TSX-V: WMD) (OTC: WDDMF) (FSE: 4WE) Ink Definitive JV Agreement to Develop Cannabis Beverages Inc.

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF), together with WeedMD (TSX-V: WMD) (OTC: WDDMF) (FSE: 4WE), this morning announced that the companies have signed a final definitive Joint Venture (“JV”) agreement to develop and operate Cannabis Beverages Inc. (“CanBev”). The strategic partnership positions CanBev as an early mover in the cannabis-infused beverage market, with each company retaining 50% each of the Class A shares in the new company. CanBev’s Board of Directors will be comprised of five individuals, two nominated by each company and one independent director. The partners have agreed to fund capital requirements of CanBev equally, beginning with initial…

WednesdayAug 15, 2018 11:55 am

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Approaches Full Capacity Oil Extraction in Test of Proprietary Closed-Loop Technology

New equipment, Cavitation Technologies agreement boosting efficiency as Petroteq launches environmentally friendly operations Company awaiting word on its application to uplist to Nasdaq Capital Market Petroteq expects to begin production at 1,000 barrels per day and ramp up to 8,000 barrels within about two years Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) (FSE: PQCF), a company actively proving its environmentally friendly, proprietary oil extraction technology, has announced the completion of continuity testing as it builds up to full capacity extraction of 1,000 barrels of oil per day utilizing the technology at its Asphalt Ridge facility in Utah’s desert tar sand-rich…

WednesdayAug 15, 2018 11:25 am

QualityStocksNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Inks Licensing Agreement with Asterion Cannabis; Engages Monster Media to Provide IR Services

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced that it has signed an agreement with Asterion Cannabis Inc. to acquire a worldwide license to use, manufacture, distribute and sell three Health Canada approved natural health products. Per the terms of the licensing agreement, Asterion has granted PreveCeutical a non-exclusive license to use Asterion's intellectual property to make or have made, use, distribute, sell, offer to sell and promote the products in exchange for a royalty fee payable to Asterion equaling 20% of the gross sales. The licensing agreement’s initial term is five years and…

WednesdayAug 15, 2018 11:20 am

QualityStocksNewsBreaks – Earth Science Tech, Inc. (ETST) Announces Initiation of Up-Listing Process

Earth Science Tech, Inc. (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, this morning announced that it has initiated the up-listing process through the OTCQB Venture Market in anticipation of approval of its Form 10 registration statement. Per the update, when the SEC declares the company’s Form 10 registration statement effective, ETST will become a fully reporting company under the Securities Exchange Act of 1934, as amended. “We decided to initiate the up-listing process in anticipation of approval of our Form 10 Registration Statement, so the up-listing process would be partially completed when…

WednesdayAug 15, 2018 11:16 am

Environment and Economy are Focuses of Auscrete Corp.’s (ASCK) Distinctive Concrete Product

Modern green movement leverages modern scientific breakthroughs Auscrete aims to increase home ownership stats ASCK lightweight concrete panels open new possibilities In a world that’s keenly aware of the impact that every action has on the environment, businesses in all types of industries are committing to operate as sustainably as possible. Auscrete Corp. (OTC: ASCK) offers a unique path to environmental responsibility and economic efficiency. The building materials manufacturing company is focused on leading the way in the “green” movement. Auscrete is acutely aware that the lack of affordable housing has reached what some are calling crisis proportions, and the…

WednesdayAug 15, 2018 10:39 am

QualityStocksNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Acquires Fitamins CBD Brand, Distribution Network

Cannabis Strategic Ventures (OTC: NUGS) this morning announced that it has signed a definitive agreement to acquire the Fitamins CBD brand. Per the terms of the agreement, Fitamins will distribute its vitamin and hemp derived CBD formulations to its network of 600+ wholesalers catered to the Asian-American market. Fitamins will also produce a proprietary CBD product as part of Cannabis Strategic’s brand portfolio, primarily targeting the United States’ distribution networks first and ultimately growing into other Asian markets that have legalized CBD products. “We have selected Fitamins because of its substantial distribution network and because of the import/export and marketing…

WednesdayAug 15, 2018 10:24 am

QualityStocksNewsBreaks – Global Payout, Inc. (GOHE) Signs Premier San Diego Dispensary to MTrac Payment Platform

Global Payout, Inc. (OTC: GOHE) this morning announced that it has successfully signed and commenced implementing one of San Diego’s premier dispensaries, The Healing Center (THC), and expects to go live with MTrac by the end of this week. Per the update, the MTrac team has already held its first training session with the THC staff and will remain on site to promote MTrac and engage the THC client base directly. “We are experiencing a very strong momentum in our local market based on our team’s incredible effort to get our message out to the industry,” Aaron Adler, CRO of…

Site Search

Company Search